IL1B and Cognitive impairment: Preclinical and clinical studies have both shown that cognitive impairment induced by AD is accompanied by elevated levels of pro-inflammatory cytokines including interleukin-1 beta (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α) [14, 15].